Clik here to view.
Programming Connection Spotlights CATIE’s Hepatitis C Ethnocultural...
CATIE’s Hepatitis C Ethnocultural Education, Outreach and Social Marketing Program works with immigrants and newcomers to develop accessible Hep C resources in multiple languages. Learn more about how...
View ArticleClik here to view.
CATIE’s HepCinfo Update 6.10
New and Noteworthy Grazoprevir and elbasvir effective in people who have never been treated before 90% cure rate in people with advanced liver injury with grazoprevir and elbasvir High levels of...
View ArticleQuestions and Answers: Prevention of sexually transmitted and blood borne...
The Centre for Communicable Diseases and Infection Control of the Public Health Agency of Canada is pleased to announce the release of a new resource entitled Questions & Answers: Prevention of...
View ArticleClik here to view.
CATIE News – Study confirms starting HIV treatment early prevents illness and...
A large, well-designed clinical trial called START has confirmed that by initiating anti-HIV therapy early—when their CD4+ cell counts are still relatively high—HIV-positive people can significantly...
View ArticleClik here to view.
CATIE News – Tesamorelin (Egrifta) comes to Canada – what you need to know
Last week, Theratechnologies Inc. began marketing a new medicine called tesamorelin (Egrifta)—licensed for the treatment of excess belly fat in some HIV-positive people. Tesamorelin causes the body to...
View ArticleClik here to view.
CATIE’s Summer 2015 Positive Side newsletter
Hot off the press: the Summer 2015 edition of The Positive Side, CATIE’s health and wellness magazine for people living with HIV. In this issue: From the Front Lines: Well, well, well… HIV...
View ArticleClik here to view.
CATIE News – A case of HIV transmission on PrEP and its implications
At the 2016 Conference on Retroviruses and Opportunistic Infections (CROI), David Knox, MD, presented information about a case of HIV transmission in a man who had multiple sexual partners and who did...
View ArticlePHAC – At a glance: Prevention of sexually transmitted and blood borne...
The Programs and Partnerships Division is pleased to announce the release of a new resource entitled At a glance: Prevention of sexually transmitted and blood borne infections among ethnocultural...
View ArticleClik here to view.
CATIE News – Leading Canadian biomedical organization recommends early...
Since the arrival of the first anti-HIV drug in the late 1980s, the question of when to begin treatment in the course of HIV disease has ignited debate. Over the years, recommendations about the ideal...
View ArticleQuestions and Answers: Prevention of sexually transmitted and blood borne...
The Centre for Communicable Diseases and Infection Control of the Public Health Agency of Canada is pleased to announce the release of a new resource entitled Questions & Answers: Prevention of...
View ArticleCATIE News – Study confirms starting HIV treatment early prevents illness and...
A large, well-designed clinical trial called START has confirmed that by initiating anti-HIV therapy early—when their CD4+ cell counts are still relatively high—HIV-positive people can significantly...
View ArticleCATIE Webinar – Understanding the experience of side effects: 50 people...
Webinar, April 12, 2017 1:00 – 2:00 p.m. ET Register here! Despite the availability of new ARVs and the simplification of treatment options, side effects continue to affect people living with HIV. Side...
View Article